Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Krogstad

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
The Pediatric Infectious Disease Journal|June 10, 2008
Fatal neonatal myocarditis caused by a recombinant human enterovirus-B variantPaul Krogstad, Rebecca Hammon, Nancy Halnon, et al.
Therapeutics and Clinical Risk Management|August 30, 2008
Enfuvirtide antiretroviral therapy in HIV-1 infectionChristina Mr Kitchen, Miriam Nuño, Scott G Kitchen, et al.
Journal of the Pediatric Infectious Diseases Society|March 12, 2026
Rising Burden of Severe Pediatric Coccidioidomycosis: A 25-Year Single Center StudySanchi Malhotra, Kristina Adachi, Ishminder Kaur, et al.
Journal of Clinical Microbiology|October 31, 2014
Serological misdiagnosis of acute liver failure associated with echovirus 25 due to immunological similarities to hepatitis A virus and prozone effectSusan K Wollersheim, Romney M Humphries, James D Cherry, et al.
Clinical Therapeutics|October 26, 2019
Host-Pathogen Interactions in Coccidioidomycosis: Prognostic Clues and Opportunities for Novel TherapiesPaul Krogstad, Royce Johnson, Maria I Garcia-Lloret, et al.
Vaccine|April 25, 2009
Packaging limits and stability of HIV-1 sequences in a coxsackievirus B vectorJohn P Miller, Yongzhi Geng, Hwee L Ng, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Discovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against EnterovirusesJun Zuo, Steve Kye, Kevin K Quinn, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2012
Fluoxetine is a potent inhibitor of coxsackievirus replicationJun Zuo, Kevin K Quinn, Steve Kye, et al.
AIDS Research and Human Retroviruses|May 29, 2010
Short communication: enhanced CD8+ T cell apoptosis in HIV-infected adolescents with virologic failure on protease inhibitor-based therapyJun Zuo, Joseph Church, Marvin Belzer, et al.
Molecular Genetics and Metabolism|November 2, 2005
Two-tiered universal newborn screening strategy for severe combined immunodeficiencySean A McGhee, E Richard Stiehm, Morton Cowan, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
The Pediatric Infectious Disease Journal|June 10, 2008
Fatal neonatal myocarditis caused by a recombinant human enterovirus-B variantPaul Krogstad, Rebecca Hammon, Nancy Halnon, et al.
Therapeutics and Clinical Risk Management|August 30, 2008
Enfuvirtide antiretroviral therapy in HIV-1 infectionChristina Mr Kitchen, Miriam Nuño, Scott G Kitchen, et al.
Journal of the Pediatric Infectious Diseases Society|March 12, 2026
Rising Burden of Severe Pediatric Coccidioidomycosis: A 25-Year Single Center StudySanchi Malhotra, Kristina Adachi, Ishminder Kaur, et al.
Journal of Clinical Microbiology|October 31, 2014
Serological misdiagnosis of acute liver failure associated with echovirus 25 due to immunological similarities to hepatitis A virus and prozone effectSusan K Wollersheim, Romney M Humphries, James D Cherry, et al.
Clinical Therapeutics|October 26, 2019
Host-Pathogen Interactions in Coccidioidomycosis: Prognostic Clues and Opportunities for Novel TherapiesPaul Krogstad, Royce Johnson, Maria I Garcia-Lloret, et al.
Vaccine|April 25, 2009
Packaging limits and stability of HIV-1 sequences in a coxsackievirus B vectorJohn P Miller, Yongzhi Geng, Hwee L Ng, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Discovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against EnterovirusesJun Zuo, Steve Kye, Kevin K Quinn, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2012
Fluoxetine is a potent inhibitor of coxsackievirus replicationJun Zuo, Kevin K Quinn, Steve Kye, et al.
AIDS Research and Human Retroviruses|May 29, 2010
Short communication: enhanced CD8+ T cell apoptosis in HIV-infected adolescents with virologic failure on protease inhibitor-based therapyJun Zuo, Joseph Church, Marvin Belzer, et al.
Molecular Genetics and Metabolism|November 2, 2005
Two-tiered universal newborn screening strategy for severe combined immunodeficiencySean A McGhee, E Richard Stiehm, Morton Cowan, et al.
Pageof 6